Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Profile: Jim Greenwood.

Stephan Herrera

    Nature Biotechnology
    |September 2, 2004
    PubMed
    Summary
    This summary is machine-generated.

    Jim Greenwood, a proponent of embryonic stem cell research and critic of corporate misconduct, will lead a major biotechnology industry organization. His transition highlights a significant shift in leadership within the biotech sector.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bonkers about biofuels.

    Nature biotechnology·2006
    Same author

    Price controls: preparing for the unthinkable.

    Nature biotechnology·2006
    Same author

    Swedish roadtrip.

    Nature biotechnology·2006
    Same author

    Profile: Eduardo Kac.

    Nature biotechnology·2005
    Same author

    Choosing a better cell line.

    Nature biotechnology·2005
    Same author

    Mexico launches bold genome project.

    Nature biotechnology·2005
    Same journal

    Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

    Nature biotechnology·2026
    Same journal

    Unlocking the chemical potential of filamentous fungi using prime editing.

    Nature biotechnology·2026
    Same journal

    A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

    Nature biotechnology·2026
    Same journal

    Prime editing for precise genome engineering and modulation of fungal metabolism.

    Nature biotechnology·2026
    Same journal

    Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

    Nature biotechnology·2026
    Same journal

    A retargeted recombinase for precise insertion of large DNA.

    Nature biotechnology·2026
    See all related articles

    Area of Science:

    • Biotechnology and life sciences policy
    • Stem cell research advocacy
    • Industry organization leadership

    Background:

    • US Congressman Jim Greenwood's career focused on supporting embryonic stem cell research.
    • Greenwood was also known for his strong stance against corporate malfeasance.
    • He is transitioning from politics to lead a prominent biotechnology industry group.

    Discussion:

    • The appointment signifies a potential shift in the biotech industry's public image and policy engagement.
    • Greenwood's background suggests a focus on ethical research practices and corporate accountability.
    • His leadership may influence regulatory and funding landscapes for biotechnology.

    Key Insights:

    • A key figure in stem cell research policy is moving into a leadership role in the biotech industry.

    Related Experiment Videos

  • The move underscores the intersection of political advocacy and industry representation.
  • This transition could impact the future direction of biotechnology policy and public perception.

    • Outlook:

    • Expect increased emphasis on ethical considerations and research funding under Greenwood's leadership.
    • Greenwood's influence may shape industry responses to regulatory challenges.
    • The biotech sector anticipates a strengthened voice in policy discussions.